Logo image of AVR

ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Price, Quote, News and Overview

NASDAQ:AVR - Nasdaq - US03675P1021 - Common Stock - Currency: USD

3.5  -0.12 (-3.31%)

After market: 3.5 0 (0%)

AVR Quote, Performance and Key Statistics

ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR (8/11/2025, 4:10:04 PM)

After market: 3.5 0 (0%)

3.5

-0.12 (-3.31%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap126.21M
Shares36.06M
Float33.55M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-15 2025-09-15
IPO12-13 2024-12-13


AVR short term performance overview.The bars show the price performance of AVR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

AVR long term performance overview.The bars show the price performance of AVR in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of AVR is 3.5 USD. In the past month the price increased by 14.01%.

ANTERIS TECHNOLOGIES GLOBAL / AVR Daily stock chart

AVR Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.81 228.55B
ISRG INTUITIVE SURGICAL INC 58.61 169.15B
BSX BOSTON SCIENTIFIC CORP 36.31 152.01B
SYK STRYKER CORP 29.31 143.95B
MDT MEDTRONIC PLC 16.86 118.82B
BDX BECTON DICKINSON AND CO 13.49 55.17B
IDXX IDEXX LABORATORIES INC 54.3 52.44B
EW EDWARDS LIFESCIENCES CORP 30.41 45.85B
RMD RESMED INC 29.77 41.69B
GEHC GE HEALTHCARE TECHNOLOGY 15.67 33.43B
DXCM DEXCOM INC 45.79 30.53B
PHG KONINKLIJKE PHILIPS NVR- NY 15.88 25.69B

About AVR

Company Profile

AVR logo image Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 136 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Company Info

ANTERIS TECHNOLOGIES GLOBAL

860 Blue Gentian Road, Suite 340

Eagan MINNESOTA US

Employees: 136

AVR Company Website

AVR Investor Relations

Phone: 16514930606

ANTERIS TECHNOLOGIES GLOBAL / AVR FAQ

What is the stock price of ANTERIS TECHNOLOGIES GLOBAL today?

The current stock price of AVR is 3.5 USD. The price decreased by -3.31% in the last trading session.


What is the ticker symbol for ANTERIS TECHNOLOGIES GLOBAL stock?

The exchange symbol of ANTERIS TECHNOLOGIES GLOBAL is AVR and it is listed on the Nasdaq exchange.


On which exchange is AVR stock listed?

AVR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ANTERIS TECHNOLOGIES GLOBAL stock?

8 analysts have analysed AVR and the average price target is 16.83 USD. This implies a price increase of 380.86% is expected in the next year compared to the current price of 3.5. Check the ANTERIS TECHNOLOGIES GLOBAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ANTERIS TECHNOLOGIES GLOBAL worth?

ANTERIS TECHNOLOGIES GLOBAL (AVR) has a market capitalization of 126.21M USD. This makes AVR a Micro Cap stock.


How many employees does ANTERIS TECHNOLOGIES GLOBAL have?

ANTERIS TECHNOLOGIES GLOBAL (AVR) currently has 136 employees.


What are the support and resistance levels for ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?

ANTERIS TECHNOLOGIES GLOBAL (AVR) has a support level at 3.15 and a resistance level at 3.63. Check the full technical report for a detailed analysis of AVR support and resistance levels.


Is ANTERIS TECHNOLOGIES GLOBAL (AVR) expected to grow?

The Revenue of ANTERIS TECHNOLOGIES GLOBAL (AVR) is expected to grow by 21.94% in the next year. Check the estimates tab for more information on the AVR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ANTERIS TECHNOLOGIES GLOBAL (AVR) stock pay dividends?

AVR does not pay a dividend.


When does ANTERIS TECHNOLOGIES GLOBAL (AVR) report earnings?

ANTERIS TECHNOLOGIES GLOBAL (AVR) will report earnings on 2025-09-15.


What is the Price/Earnings (PE) ratio of ANTERIS TECHNOLOGIES GLOBAL (AVR)?

ANTERIS TECHNOLOGIES GLOBAL (AVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.12).


What is the Short Interest ratio of ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?

The outstanding short interest for ANTERIS TECHNOLOGIES GLOBAL (AVR) is 2.78% of its float. Check the ownership tab for more information on the AVR short interest.


AVR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AVR.


Chartmill TA Rating
Chartmill Setup Rating

AVR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AVR. AVR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AVR Financial Highlights

Over the last trailing twelve months AVR reported a non-GAAP Earnings per Share(EPS) of -2.12. The EPS decreased by -65.77% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -129.76%
ROE -176.36%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-65.77%
Revenue 1Y (TTM)-1.16%

AVR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to AVR. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 26.6% and a revenue growth 21.94% for AVR


Ownership
Inst Owners57.36%
Ins Owners0.21%
Short Float %2.78%
Short Ratio4.03
Analysts
Analysts80
Price Target16.83 (380.86%)
EPS Next Y26.6%
Revenue Next Year21.94%